… cytokines and inflammatory mediators include interleukin-1 (IL-1), interleukin-6 (IL-6), and
other interleukins, tumor necrosis factor alpha (TNF-α), and interleukin-33 receptor soluble …

… Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-,
not responsive to IL-1) or the IL-1 … a model of severe ischemic cardiomyopathy due to …

… myocarditis was diagnosed. Two days after administration of immunoglobulin, the serum
level of interleukin-6 … We conclude that there are cases of acute myocarditis in which high-dose …

… The higher levels of IL-1RA in children with severe disease course may represent the
immunologic reaction of a more fulminant myocarditis pointing towards potential therapeutic …

… in viral myocarditis induced by encephalomyocarditis virus (EMCV) in mice, we evaluated (1)
… In summary, IL-6 reduces myocardial damage in mice with viral myocarditis. Modification of …

… For fulminant, acute, and chronic autoreactive myocarditis, immunosuppressive treatment …
ESETCID trials; for viral cardiomyopathy and myocarditis, intravenous immunoglobulin IgG …

… fulminant myocarditis. α-Myosin-expanded T cells from the peripheral blood of patients with
ICI-myocarditis … Th17 cells, which produce interleukin-17, have been shown to play a role in …

… patient would have developed fulminant myocarditis, but this … the incidence of subclinical
myocarditis, its natural history and … dilated cardiomyopathy or reduce progression to fulminant …

… lymphocytic myocarditis … myocarditis compared with no psoriatic myocarditis and a six-fold
increase compared to myocardial controls. Treatment included combination of prednisone (1 …

… of cardiac disease in the myocarditis group. Patients with suspected myocarditis were older,
had … more prolonged hospitalization and a lower value of interleukin-6 than other COVID-19 …